BioSpace News Archive

Job Trends

Mineralife Launches MG Labs Hemp Extract Oils

MG Labs Provides Consistent, Quality Products to a New Health Market

January 14, 2019
·
1 min read
BioMidwest

Quadax Presents Strategic Considerations for Managing the Increasing Patient Cost-Share Trend

Quadax Inc. will present strategies for laboratories to improve collections and reduce administrative burden at the 14th Semi-Annual Q1 Diagnostic Coverage & Reimbursement Conference West

January 14, 2019
·
2 min read
Drug Development

Array BioPharma Announces 15.3 Months Median Overall Survival from the Safety Lead-in of the Phase 3 BEACON CRC Trial of the Combination BRAFTOVI®, MEKTOVI® and ERBITUX® in BRAF-Mutant Metastatic Colorectal Cancer

Data will be presented at ASCO 2019 Gastrointestinal Cancers Symposium

January 14, 2019
·
19 min read
Drug Development

Merck’s KEYTRUDA® (pembrolizumab) Reduced Risk of Death by 31 Percent Compared to Chemotherapy in Previously Treated Patients with Advanced Esophageal or Esophagogastric Junction Carcinoma Whose Tumors Expressed PD-L1 (CPS ≥10)

Results from Phase 3 KEYNOTE-181 Trial to be Presented at 2019 Gastrointestinal Cancers Symposium (ASCO GI)

January 14, 2019
·
31 min read
Drug Development

Post-Hoc Analyses from Pivotal Phase 3 REFLECT Trial of LENVIMA® (lenvatinib) in Unresectable Hepatocellular Carcinoma to be Presented at 2019 Gastrointestinal Cancers Symposium

Eisai Inc. announced the presentation of four abstracts at the 2019 Gastrointestinal Cancers Symposium (#GI19), taking place in San Francisco from January 17-19, 2019

January 14, 2019
·
17 min read
Biotech Bay

An Innovative Approach to Pricing Drugs Can Accelerate the Eradication of Diseases

BCG’s Analysis of Hepatitis C Cures Reveals That a Payer Licensing Agreement Is More Advantageous--For Patients, Payers, and Pharmaceutical Companies--Than the Current Approach

January 14, 2019
·
3 min read
Drug Development

Exelixis Announces U.S. FDA Approval of CABOMETYX® (cabozantinib) Tablets for Previously Treated Hepatocellular Carcinoma

Approval based on statistically significant and clinically meaningful overall survival benefit demonstrated in the CELESTIAL phase 3 pivotal trial

January 14, 2019
·
15 min read
Business

Gravie Hires Charles Marentette as Chief Financial Officer to Support Company’s Rapid Growth

Gravie, a company that’s been reinventing health benefits since 2013, announced that Charles Marentette has joined the team as Chief Financial Officer.

January 14, 2019
·
2 min read
Business

Partners Marie Napoli and Nicholas Farnolo Appointed to Leadership Roles in Zimmer Product Liability Litigation

Napoli Shkolnik PLLC is proud to announce that Founding Partner Marie Napoli and Partner Nicholas R. Farnolo have been appointed to the Plaintiffs’ Steering Committee in the In Re: Plaintiffs’ Steering Committee for In Re: Zimmer M/L Taper Hip Prosthesis Or M/L Taper Hip Prosthesis With Kinectiv Technology And Versys Femoral Head Products Liability Litigation (18-MD-2859-PAC) by United Stated District Judge Jesse M. Jurman.

January 14, 2019
·
1 min read
Drug Development

Five Prime Therapeutics Announces Two Poster Presentations at the 2019 Gastrointestinal Cancers Symposium

Phase 1 Results from the Phase 1/3 FIGHT Study Evaluating Bemarituzumab and mFOLFOX6 in Advanced Gastric and Gastric Esophageal Junction (GEJ) Cance

January 14, 2019
·
4 min read